Fulgent Genetics
FLGT
142 hedge funds and large institutions have $334M invested in Fulgent Genetics in 2026 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 46 reducing their positions, and 16 closing their positions.
1,327% more call options, than puts
Call options by funds: $4.71M | Put options by funds: $330K
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
1% more funds holding
Funds holding: 141 → 142 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 46
0.13% less ownership
Funds ownership: 55.25% → 55.12% (-0.13%)
20% less capital inflows, than outflows
Capital inflows: $43.4M | Capital outflows: $54.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$10.6M |
| 2 |
Diametric Capital
Boston,
Massachusetts
|
+$4.71M |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$3.63M |
| 4 |
BlackRock
New York
|
+$3.08M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invenomic Capital Management
Boston,
Massachusetts
|
-$10.2M |
| 2 |
JP Morgan Chase
New York
|
-$4.83M |
| 3 |
Millennium Management
New York
|
-$4.63M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.99M |
| 5 |
Medina Value Partners
Los Angeles,
California
|
-$3.96M |
FLGT Hedge Fund Activity: Q3 2026 in Review
142 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2026, worth a combined $334M — up 3.8% from $322M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new FLGT positions and 16 closed out — a net gain of 2 holders — while 46 added to existing stakes and 46 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $10.6M. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $10.2M sold.
- 142 institutional investors held Fulgent Genetics (FLGT) as of Q3 2026, up from 141 in Q2 2026.
- Funds reported $334M of Fulgent Genetics stock for Q3 2026, up 3.8% quarter-over-quarter.
- 18 funds opened new Fulgent Genetics positions in Q3 2026 and 16 closed out, a net change of +2 holders.
- The largest Fulgent Genetics buyer in Q3 2026 was Two Sigma Investments, an estimated $10.6M added.
- The largest Fulgent Genetics seller in Q3 2026 was Invenomic Capital Management, an estimated $10.2M sold.
Based on aggregated 13F filings for Q3 2026.